Work

Survival, biomarker, and toxicity analysis of nivolumab (NIVO) in patients that progressed on ipilimumab (IPI).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.9055

Authors: Jeffrey S. Weber, Geoffrey Thomas Gibney, Bin Yu, PingYan Cheng, Alberto J Martinez, Jodi Kroeger, Jillene Freed, Allison Richards, Xiuhua Zhao, Michael J. Schell

Institution: Moffitt Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2463257517

Cites:

Cited by: 15

Related to: 10